FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to chemical-pharmaceutical industry and deals with pharmaceutical composition of tablet, based on matrix, which contains alfozosin hydrochloride, polyvinylpyrrolidone, lactose and mixture HPMC K100, HPMC K100M and HPMC K15M, with controlled release.
EFFECT: form of tablet implementation ensures simplicity of tablet manufacturing and acceptable profile of alfuzosin release.
10 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG COMPOSITIONS CONTAINING CONTROLLED RELEASE HYPROMELLOSE MATRIXES | 2006 |
|
RU2414241C2 |
| MODIFIED RELEASE THERAPEUTIC SYSTEMS FOR ORAL ADMINISTRATION OF CURCUMIN IN TREATING INTESTINAL DISORDERS | 2014 |
|
RU2692473C1 |
| TABLETS OF TAMSULOSIN WITH MODIFIED RELEASE | 2002 |
|
RU2335280C2 |
| TABLET WITH THE SLOWED DOWN LIBERATION, CONTAINING A ALFUZOSIN HYDROCHLORIDE | 2010 |
|
RU2442570C1 |
| PHARMACEUTICAL COMPOSITION OF SLOW RELEASE, CONTAINING APLINDOR AND ITS DERIVATIVES | 2004 |
|
RU2376988C2 |
| PROLONGED-RELEASE ORAL TEDISAMIL COMPOSITION RETAINED IN STOMACH | 2005 |
|
RU2385724C2 |
| CONTROLLED-RELEASE PHARMACEUTICAL TABLET FOR ORAL ADMINISTRATION METHODS FOR PREPARATION THEREOF | 2011 |
|
RU2603469C2 |
| TAMZULOSIN TABLETS | 2002 |
|
RU2311903C2 |
| ORAL PHARMACEUTICAL COMPOSITION SUITABLE FOR IMPROVING EFFECTIVENESS OF TREATMENT OF MOTOR DISORDERS | 2013 |
|
RU2670272C2 |
| PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE WITH ANTIPSYCHOTIC ACTIVITY AND SYNTHESIS METHODS THEREOF | 2012 |
|
RU2584653C2 |
